Position in NTRA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$215,189
-$30,395 QoQ
Shares Held
1,076
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Kovack Advisors, Inc. holds $5,774,111 across 7 Diagnostics & Research names. NTRA ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WGS |
GeneDx Holdings Corp.
|
33,960 | $2,180,911 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
2,652 | $1,490,132 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
1,404 | $690,108 | |
| 4 | OPK |
Opko Health, Inc.
|
459,700 | $524,058 | |
| 5 | DHR |
Danaher Corp /De/
|
1,822 | $345,451 | |
| 6 | A |
Agilent Technologies, Inc.
|
2,880 | $328,262 | |
| 7 | NTRA |
Natera, Inc.
This page
|
1,076 | $215,189 |
All Filings in NTRA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $215,189 | 1,076 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $245,584 | 1,072 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||